Literature DB >> 12939423

Language function and dysfunction in corticobasal degeneration.

Naida L Graham1, Thomas Bak, Karalyn Patterson, John R Hodges.   

Abstract

OBJECTIVE: S: The authors assessed language functioning in corticobasal degeneration (CBD), an area that has received little systematic study. Aphasia has been reported occasionally, and the authors hypothesized that appropriate assessments would reveal at least mild language impairment, particularly affecting phonologic (sound-based) processing, even in cases without frank aphasia.
METHODS: A series of 10 unselected patients with CBD (one with pathologic confirmation) were administered neuropsychological tests assessing the following aspects of cognitive functioning: verbal fluency, naming, reading, oral spelling, auditory-verbal short-term memory, phoneme blending and segmentation, visuospatial skills, and semantic memory.
RESULTS: Phonologic and spelling impairments were prevalent, even in nonaphasic patients. The prevalence of visuospatial, constructional, and frontal impairments, demonstrated in previous research, was also replicated. A minority of patients had deficits in semantic memory, naming, and reading, but the impairments were usually mild.
CONCLUSIONS: The authors found phonologic impairment to be a typical feature of CBD. There is substantial overlap between progressive nonfluent aphasia and CBD, and the linguistic impairment can be thought of as a continuum, with mild phonologic impairment at one end and severe aphasia at the other.

Entities:  

Mesh:

Year:  2003        PMID: 12939423     DOI: 10.1212/01.wnl.0000081230.09863.ed

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

Review 1.  The corticobasal syndrome-Alzheimer's disease conundrum.

Authors:  Anhar Hassan; Jennifer L Whitwell; Keith A Josephs
Journal:  Expert Rev Neurother       Date:  2011-11       Impact factor: 4.618

2.  Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease.

Authors:  Katherine P Rankin; Mary Catherine Mayo; William W Seeley; Suzee Lee; Gil Rabinovici; Maria Luisa Gorno-Tempini; Adam L Boxer; Michael W Weiner; John Q Trojanowski; Stephen J DeArmond; Bruce L Miller
Journal:  J Mol Neurosci       Date:  2011-09-01       Impact factor: 3.444

3.  Parkinsonism and frontotemporal dementia: the clinical overlap.

Authors:  Alberto J Espay; Irene Litvan
Journal:  J Mol Neurosci       Date:  2011-09-03       Impact factor: 3.444

4.  The association of aphasia and right-sided motor impairment in corticobasal syndrome.

Authors:  Johannes Levin; Thomas H Bak; Axel Rominger; Erik Mille; Thomas Arzberger; Armin Giese; Nibal Ackl; Stefan Lorenzl; Benedikt Bader; Maximilian Patzig; Kai Bötzel; Adrian Danek
Journal:  J Neurol       Date:  2015-07-05       Impact factor: 4.849

5.  Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report.

Authors:  Maria Luisa Gorno-Tempini; Ryan C Murray; Katherine P Rankin; Michael W Weiner; Bruce L Miller
Journal:  Neurocase       Date:  2004-12       Impact factor: 0.881

6.  Frontotemporal dementia and primary progressive aphasia: an update.

Authors:  Howard S Kirshner
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

7.  Sound naming in neurodegenerative disease.

Authors:  Maggie L Chow; Simona M Brambati; Maria Luisa Gorno-Tempini; Bruce L Miller; Julene K Johnson
Journal:  Brain Cogn       Date:  2010-01-20       Impact factor: 2.310

8.  Criteria for the diagnosis of corticobasal degeneration.

Authors:  Melissa J Armstrong; Irene Litvan; Anthony E Lang; Thomas H Bak; Kailash P Bhatia; Barbara Borroni; Adam L Boxer; Dennis W Dickson; Murray Grossman; Mark Hallett; Keith A Josephs; Andrew Kertesz; Suzee E Lee; Bruce L Miller; Stephen G Reich; David E Riley; Eduardo Tolosa; Alexander I Tröster; Marie Vidailhet; William J Weiner
Journal:  Neurology       Date:  2013-01-29       Impact factor: 9.910

9.  Measuring disease progression in corticobasal syndrome.

Authors:  Nancy Huang; Michael Hornberger; John R Hodges; James R Burrell
Journal:  J Neurol       Date:  2014-06-04       Impact factor: 4.849

10.  Corticobasal degeneration.

Authors:  Stephen G Reich; Stephen E Grill
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.